Semisynthetic penicillinase-resistant penicillins are recommended for therapy of Staphylococcus aureus endocarditis, but evaluation of the efficacy and safety of individual agents has received little attention. At The New York Hospital, 11 heroin addicts and 5 nonaddicts were treated with nafcillin. The 11 addicts did well clinically, but four of the five nonaddicts had severe complications, and three of them died. Important adverse reactions to nafcillin occurred in two patients: one developed leukopenia, and one developed an extensive rash. Methicillin was employed to treat two heroin addicts and four nonaddicts. Five of the six patients were cured bacteriologically, but three patients developed nephritis and one patient developed an extensive rash. Nafcillin appears to be highly efficacious for the treatment of S. aureus endocarditis, yielding results at least equal to those obtained with other drugs. Because adverse reactions appear to occur more frequently with methicillin than with nafcillin, we regard nafcillin as the preferable penicillinase-resistant penicillin for the treatment of S. aureus endocarditis.
endocarditis in both heroin addicts and nonaddicts has recently been detailed, the relative efficacy and safety of the penicillinase-resistant penicillins have received little attention (2, 20, 27, 28) . In this report, our experience with nafcillin in the treatment of S. aureus endocarditis is detailed.
MATERIALS AND METHODS
Clinical and autopsy records of all patients with two or more blood cultures positive for S. aureus, or a discharge diagnosis of S. aureus endocarditis during the period of 1971 to 1977, were reviewed. A diagnosis of S. aureus endocarditis was established on the basis of one of the following criteria: isolation of S. aureus from at least two separate blood cultures in a patient with a syndrome compatible with endocarditis; isolation of S. aureus from one blood culture during life, in addition to autopsy confirmation of endocarditis; isolation of S. aureus from heart blood or vegetations on the heart, in addition to the presence of gram-positive cocci on the vegetation. S. aureus isolates were identified by the Microbiology Laboratory of The New York Hospital on the basis of morphology, coagulase reaction, and deoxyribonuclease production.
Patients concentrations of nafcillin against these 16 S. aureus isolates were 0.1 to 0.8 ug/ml (mean, 0.4 ,ug/ml). The minimum bactericidal concentrations of nafcillin against the 16 S. aureus isolates were 0.1 to 1.6 pug/ml (mean, 0.4 pg/ml). The dose of nafcillin employed was 6 to 12 g/day (median, 9 g/day), except in one child who received 4 g/day. Peak serum inhibitory levels ranged from 1:32 to 1:1,024 (median, 1:128); peak serum bactericidal levels ranged from 1:16 to 1:512 (median, 1:128).
The extracardiac complications in the 11 heroin addicts included cavitating pneumonia in 4 patients and a cerebral embolus, a pulmonary embolus, a septic joint, and osteomyelitis in 1 patient each. All 11 addicts were discharged from the hospital with no clinical or bacteriological evidence of endocarditis. Six were available for follow-up study-, five had no evidence of relapse 6 months to 4 years after discharge. One patient, however, had another episode of S. aureus endocarditis 1 year after discharge, but had continued to use heroin in the interim period.
Four of the five nonaddicts had relatively severe complications associated with endocarditis. Patient 10 was admitted to the hospital comatose, developed chronic disseminated intravascular coagulation, and after 22 days of therapy died due to a cerebral hemorrhage despite bacteriological cure. Patient 11 died suddenly of an apparent arrhythmia after 36 days of therapy. Patient 12 had osteomyelitis but is doing well 1 year after discharge. Patient 16 developed an adverse reaction to nafcillin after 24 days of therapy, finished her 6-week course of antibiotics with vancomycin, but relapsed and died shortly thereafter. Patient 16 was the only patient in this series with a prosthetic heart valve. The fifth patient (no. 9) did well for 6 months after termination of therapy, with no evidence for recurrence, but died suddenly.
Two of the 16 (2, 14, 16, 20, (27) (28) (29) . From 1971 to 1977 at The New York Hospital, 29 episodes of S. aureus endocarditis in 27 patients were documented. Twelve patients were treated with nafcillin alone, two patients were treated with nafcillin in combination with gentamicin, and in two patients nafcillin therapy was replaced by another antimicrobial regimen.
Nafcillin was highly efficacious in the eight heroin addicts with right-sided endocarditis who received 27 to 43 days of this antimicrobial agent alone. Complications of endocarditis after therapy was initiated were few; one addict had a cerebral embolus and another a pulmonary embolus during therapy. Each addict was discharged with no clinical or bacteriological evidence of endocarditis. Five of the addicts were available for follow-up study: four had no recurrence of their endocarditis 1 to 4 years after discharge; one was well 3 months after discharge. Two addicts treated with nafcillin and gentamicin, and one patient whose nafdilhin therapy was changed to methicillin upon transfer to another hospital, also had no evidence of disease at the time of hospital discharge.
The favorable prognosis ofheroin addicts with S. aureus endocarditis in our series is similar to the experience reported from other institutions (2, 14, 20, 27, 28) . Although systemic complications ofendocarditis were not infrequent in those series, bacteriological failures or deaths were unusual. The efficacy of individual antibiotics was not evaluated, but most patients were treated with either methicillin, a cephalosporin, or a combination of agents. It would appear that these other regimens have no advantage over nafcillin in terms of efficacy.
In contrast, the prognosis in the five non-heroin addicts with left-sided endocarditis treated with nafcillin in our series was distinctly unfavorable. The one patient who failed to achieve bacteriological cure had a prosthetic aortic valve. Of the other four patients, two died during therapy; the other two patients had no indication of relapse 6 months after discharge. Experience at other institutions has been similarly ANTIMICROB. AGENTS CHEMOTHER. unfavorable in nonaddicts with S. aureus endocarditis (14, 16, 29, 30) . Mortality has been greater than 50% in several of these series. Poor prognosis was associated with age (>50 years), underlying cardiac disease, or underlying systemic diseases such as diabetes mellitus, alcoholism, or cirrhosis (30) . Of our five nonaddicts, three had underlying heart disease, and four were >50 years old. In other series, methicillin, nafcillin, a cephalosporin, clindamycin, and vancomycin were used alone or in combination with other drugs (2, 3, 7, 28, 30) . No one regimen has been clearly shown to be most efficacious.
Adverse reactions to nafcillin have rarely been reported. Nafcillin-induced agranulocytosis similar to that seen in our patient has been reported in two previous cases (19, 24) . In each instance, bone marrow examination revealed maturation arrest at the myelocyte stage; neutrophils were detected in the peripheral blood promptly, and white blood counts were nornal within 1 to 3 weeks. Although granulocytopenia was not apparent among our six patients treated with methicillin, methicillin-induced granulocytopenia has been documented in at least eight patients (6, 8, 16, 17, 26) . Bone marrow findings and reversibility of the abnormality have been similar to those with nafcillin. The mechanism by which nafcillin or methicillin leads to maturation arrest is unknown, although a direct toxic effect on the bone marrow has been suggested (19) .
Nafcillin-induced nephritis has been reported previously, although the patient had been treated with methicillin as well (23) . Numerous cases of nephritis have been attributed to methicillin (1, 4, 5, 10-13, 15, 22) . In our series, three of six patients receiving methicillin developed an active urinary sediment, abnormal creatinine, and fever or rash, all ofwhich promptly remitted after methicillin was discontinued. Similar findings were not observed in patients receiving nafcillin. Although the mechanism by which nafcillin or methicilhin causes nephritis is also unknown, a role for drug-induced antitubular basement membrane antibodies has been proposed (4). Methicillin nephritis does not appear to be dose related, and thus the higher incidence of nephritis with methicillin as opposed to nafcillin is probably unrelated to the higher doses of methicillin that are used (10) .
The only other adverse reaction to nafcillin noted in our series was a generalized maculopapular rash in two patients. The rash was selflimiting and did not necessitate alteration in antimicrobial therapy. A similar rash was also observed in one of the six patients treated with methicillin.
Nafcillin is highly efficacious for the treatment 
